Navigation Links
Beckman Coulter Announces Fourth Quarter and Full Year 2008 Results; Earnings Outlook Achieved on Strong Fundamentals
Date:2/9/2009

---- ---- Total stockholders' equity 1,436.0 1,441.7 ------- ------- Total liabilities and stockholders' equity $3,572.8 $3,594.3 ======== ======== BECKMAN COULTER, INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in millions) (unaudited) Year Ended December 31, ----------------------- 2008 2007 ---- ---- Cash flows from operating activities Net earnings $194.0 $211.3 Less: Earnings from discontinued operations, net of tax - 1.6 --- --- Earnings from continuing operations 194.0 209.7 Adjustments to reconcile net earnings to net cash provided by operating activities Depreciation and amortization 255.9 203.0 Provision for doubtful accounts receivable 6.8 4.7 Share-based compensation expense 29.6 24.5 Gain on sales of building and land (5.1) (26.8) Environmental remediation obligation 18.4 - U.S. pension trust contributions (8.2) (9.3) In-process research and development - 35
'/>"/>
SOURCE Beckman Coulter - IR
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Beckman Coulter to Present at the Bear Stearns Healthcare Conference
2. Beckman Coulter to Present at the UBS Global Life Sciences Conference
3. Beckman Coulter Announces Third Quarter 2007 Earnings to Be Released on Tuesday, October 30, 2007 Before Market Opens
4. Beckman Coulter Declares Quarterly Dividend
5. Beckman Coulter Announces Third Quarter 2007 Results
6. Beckman Coulter to Present at the 19th Annual Piper Jaffray Healthcare Conference
7. Beckman Coulter to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
8. Beckman Coulter to Acquire Exclusive Rights to Break-Through Technologies
9. Beckman Coulter Elects AMN Healthcare Executive to Board of Directors
10. Beckman Coulter to Present at the JPMorgan Healthcare Conference
11. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...LEDO recently announced that Dr. Dominique Hebraul...Process Analytical Technology (PAT) in Green Chemi...009. , (PRWEB) November 2...cal Technology (PAT) in Green Chemistry and Green ...ical Technology (PAT) case studies will be present...
(Date:11/19/2009)...swire/ -- Danish Prince Joachim inaugurated the DO...Kalundborg, Denmark, on Wednesday, November 18. Th... 2nd generation ethanol demonstration biorefinerie...plant,s innovative process for converting straw to...rst to market with commercial enzymes for converti...
(Date:11/19/2009)...PRNewswire/ -- Dr. Mate Hidvegi, inventor of Avema...s release issued on November 17 by Biropharma Kft,...se and self-serving statements about its U.S. comp...ated from his office in Budapest, Hungary: ,, ... not apply to AveULTRA, www.aveultra.com , is m...
(Date:11/19/2009)...wire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS ...letter to its shareholders, discussing the Company...harmaceuticals Holdings, Inc. (CHBP), an integrate... Republic of China. The merger gives NeoStem a con...l Co. Ltd., CHBP,s primary operating subsidiary an...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3
...e the money and run. Like a thief across a neighbo... in the night. Take the money and run. Cause you f... run." - Excerpted from Take the money and run, w...ened again. Another imperious and embattled CEO wa... tractor trailer load of severance pay. This time ...
...field, Wis. - Citing one-time gains due to Hurric...05, Fiserv has reported a net loss of nearly $45...arter of 2006. , ,The information management servi...wn from the $150.5 million reported in the fourth ...crease was attributed in part to unpredictable eve...
...ukee, Wis. - In a visit to the Menomonee Valley, ... million in his 2007-09 state budget for the new W...ion would go to the public-private sector partners...f capital, and serve as an entry point of contact ...oncept was announced in December of 2006 for the p...
Other Biology Technology:CEOs Gone Wild? Risks and rewards in the executive suite 2CEOs Gone Wild? Risks and rewards in the executive suite 3CEOs Gone Wild? Risks and rewards in the executive suite 4CEOs Gone Wild? Risks and rewards in the executive suite 5CEOs Gone Wild? Risks and rewards in the executive suite 6Doyle proposes $2M for venture capital center 2
(Date:11/20/2009)...ublished in the November 2009 issue of the journal...s show how a family of genes (1-aminocyclopropane-...ble for production of ethylene. This gas affects m...tion lays the foundation for future genetic manipu...ble to survive and thrive in difficult terrain, in...
(Date:11/20/2009).... 20, 2009) Scientists from the Marine Biogeochem...aval Research Laboratory (NRL) organized and led a...n Arctic expedition to initiate methane hydrate ex...atial variation of sediment contribution to Arctic...d Cutter Polar Sea as a research platform, three c...
(Date:11/20/2009)... 2009 - Bacteria possess an ingenious mechanism fo...ks of the cell. This is the new finding of a team ...a life sciences research institute in Flanders, Be.... The scientists made this discovery by modifying ...oli . By means of this model organism, they have u...
Breaking Biology News(10 mins):It's a gas: New discovery may lead to heartier, high-yielding plants 2International expedition investigates climate change, alternative fuels in Arctic 2Biologists discover bacterial defense mechanism against aggressive oxygen 2Vaporized viral vector shows promise in anti cancer gene therapy 48186 1Vaporized viral vector shows promise in anti cancer gene therapy 48186 2Researchers work to boost effectiveness of the flu vaccine 48184 1Researchers work to boost effectiveness of the flu vaccine 48184 2Researchers work to boost effectiveness of the flu vaccine 48184 3Researchers shed light on trading behavior in animals and humans 8746 1Researchers shed light on trading behavior in animals and humans 8746 2
...en at high risk for breast cancer do not increase ..., according to a new analysis by researchers from ...cMaster University in Ontario, Canada. In addition...aordinarily expensive cancer-prevention strategy, ...aved. The study will be published in the Sept. 1 i...
...coral reefs of Madagascar,s northeast coast have s...n temperatures attributed to global climate change..., The survey of a previously unexplored region in ...tional and its partners documented a much greater ...species believed new to science and 17 others note...
... introduction of just four factors, researchers ha... from mouse embryos or adult mice to behave like e...r findings in an immediate early publication of th...lls--which the researchers designate "induced plur...rowth, and genetic characteristics typical of embr...
Other Biology News:Tamoxifen for breast cancer prevention does not benefit most women 2Tamoxifen for breast cancer prevention does not benefit most women 3Healthy coral reefs of Madagascar resisting damage from climate change 2With few factors, adult cells take on character of embryonic stem cells 2
Goat Anti-MLH3 Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human IRF7 Antibody, Unconjugated from ABR-Affinity BioReagents
Mouse Anti-DNA-PKcs, phospho (Thr2609) Monoclonal Antibody, Unconjugated, Clone 10B1 from BioLegend
Rabbit Anti-Coronin / CORO1C Polyclonal Antibody, Unconjugated from IMGENEX
Biology Products: